Target intelligence / Profile preview

Mouse peritoneal macrophage

Molecular classification
Other (immune cell population)
01

Overview

Mouse peritoneal macrophages are a heterogeneous population of immune cells residing freely in the peritoneal cavity of mice. They are divided into two principle subsets: large peritoneal macrophages (LPMs), characterized by high expression of F4/80, CD11b, low MHCII, and GATA6, which are long-lived, tissue-resident and embryonic in origin; and small peritoneal macrophages (SPMs), which originate from bone marrow-derived monocytes in response to inflammation, expressing low F4/80 and high MHCII. Both subsets are essential for immune homeostasis, phagocytosis, regulation of local inflammation, and response to infection or injury. Peritoneal macrophages are heavily studied in experimental models for their role in infection, inflammation, cancer metastasis, adhesion formation post-surgery, and other peritoneal diseases. Their complex dynamics and function are regulated by tissue-derived signals, transcription factors, and environmental changes. This entry is not for a specific molecule or receptor but for a cell type used in experimental immunology. Please clarify if a molecular target is intended.

Other names
Peritoneal macrophage (mouse)Peritoneal resident macrophageLarge peritoneal macrophage (LPM; for subset)Small peritoneal macrophage (SPM; for subset)
02

Mechanism of action

Not applicable; as a cell population rather than a molecular target, peritoneal macrophages respond to immunomodulators, anti-inflammatories, or chemotherapeutics via indirect mechanisms (e.g., suppression, stimulation, depletion).

03

Biological functions

Immune surveillancePhagocytosisInflammatory responseHomeostasisClearance of apoptotic cellsTissue repairRegulation of B1 cells and antibody production
04

Disease associations

InfectionInflammationCancer (especially peritoneal metastasis)Post-surgical adhesionAutoimmune disease (e.g., peritoneal serositis)Endometriosis
05

Biomarkers

F4/80 (high in LPMs)CD11bMHCII (high in SPMs)CD14CD64MerTK (resident macrophage markers)GATA6 (transcription factor for LPMs)

Beyond the preview

Go deeper on Mouse peritoneal macrophage.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mouse peritoneal macrophage.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call